Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of the universal two-child policy on obstetric issues.

European journal of obstetrics, gynecology, and reproductive biology·2020
Same author

Evaluation of the detection of 14 high-risk human papillomaviruses with HPV 16 and HPV 18 genotyping for cervical cancer screening.

Experimental and therapeutic medicine·2013
Same author

Hybrid capture II for high-risk human papillomavirus DNA testing to detect cervical precancerous lesions: A qualitative and quantitative study.

Experimental and therapeutic medicine·2012
Same author

Feasibility of laparoscopic extraperitoneal pelvic lymphadenectomy in gynecologic malignancies.

Gynecologic oncology·2011
Same author

In vivo tracking of superparamagnetic iron oxide nanoparticle-labeled mesenchymal stem cell tropism to malignant gliomas using magnetic resonance imaging. Laboratory investigation.

Journal of neurosurgery·2008
Same author

Reversible self-association of a concentrated monoclonal antibody solution mediated by Fab-Fab interaction that impacts solution viscosity.

Journal of pharmaceutical sciences·2008

Related Experiment Video

Updated: May 6, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

10.5K

[Evaluation of variable methods for HPV testing].

Jiao-ying Cheng1, Mei-lu Bian, Li Ma

  • 1Department of Obstetrics and Gynecology, China-Japan Friendship Hospital, Beijing 100029, China.

Zhonghua Fu Chan Ke Za Zhi
|November 9, 2013
PubMed
Summary
This summary is machine-generated.

Liquid-based cytology combined with PCR genotyping effectively identifies high-grade cervical intraepithelial neoplasia (CIN II or above). This HPV testing method shows high sensitivity and specificity for detecting cervical cancer precursors.

More Related Videos

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

11.4K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

29.0K

Related Experiment Videos

Last Updated: May 6, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

10.5K
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

11.4K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

29.0K

Area of Science:

  • Oncology
  • Virology
  • Gynecology

Background:

  • Cervical cancer screening relies on detecting precancerous lesions.
  • Human Papillomavirus (HPV) is the primary cause of cervical cancer.
  • Accurate HPV detection methods are crucial for early diagnosis and treatment.

Purpose of the Study:

  • To compare the clinical efficacy of different HPV testing methods for cervical cancer screening.
  • To evaluate the performance of liquid-based cytology (LCT) combined with Hybrid Capture II (HC-II) versus real-time PCR (RT-PCR) for HPV genotyping.

Main Methods:

  • A study involving 424 women at China-Japan Friendship Hospital.
  • Participants underwent LCT, HC-II, and RT-PCR for high-risk HPV DNA testing (HPV16 and HPV18 genotyping).
  • Comparison of LCT+HC-II and LCT+RT-PCR groups, with colposcopy and biopsy for suspicious cases.

Main Results:

  • No significant difference in detecting cervical intraepithelial neoplasia (CIN) II or above between LCT+HC-II and LCT+RT-PCR groups.
  • RT-PCR showed high sensitivity (96.3%) and specificity (78.2%) for CIN II or above detection.
  • HPV 16 and HPV 18 infections were associated with a higher likelihood of CIN II or above compared to other high-risk HPV types.

Conclusions:

  • Liquid-based cytology combined with PCR genotyping is an efficient method for identifying CIN II or above disease.
  • This combined approach offers a reliable strategy for cervical cancer screening and early detection.